Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Healthcare Copper
Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Medivolve Inc > New Platfrom to deliver BLOWFISH results
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1060)
•••
Comment by Hiddensecretson May 06, 2021 9:19am
69 Views
Post# 33139493

RE:RE:New Platfrom to deliver BLOWFISH results

RE:RE:New Platfrom to deliver BLOWFISH resultsMEDV will recover the cost of the platform by charging each client around the world a fee, say $ 9.99 per year. 

And the platform would be used for covi19, adxit, blowfish, telehealth, etc....

Even if Marvel walked away, MEDV would still get 42% of its revenue around the world. 

You cannot grow if you always act with DOUBT and FEAR.    Imagine MEDV telling Marvel, we do not trust you and, refuse to acquire a platform.   Is this the message they are to give to them?   Marvel would then say, then why did you acquire 42%?

Instead MEDV invests in the platform showing that they trust them and are serious about GROWTH. 

This was the next logicial step in becoming a TELEDIAGNOSTIC company, you needed a platform of some sort for the medical / patient industry.   Each company that operates in this industry has their own. 

MPO


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested